Abstract
RESULTS:
A total of 1596 patients with AMI were enrolled to this study, but data of only 1210 cases are accessible till follow-up. We classified the patients based on the exposure levels of SQABC. When comparing the results between all exposure and non-exposure groups, significant differences were identified, both during hospitalization and follow-ups. During hospitalization, cardiac death (4.40% vs 21.55% , P < 0.05) and cardiac shock (3.04% vs 11.62%, P < 0.05) were significantly lower in the exposure group than the non-exposure group. Similarly, during the follow-up, cardiac death (12.04% vs 20.49%, P < 0.05), acute heart failure (7.27% vs 11.81% , P < 0.05), composite endpoint of reinfarction and stroke (9.11% vs 15.28% , P < 0.05), and rehospitalization due to angina (25.49% vs 34.38%, P < 0.05) were significantly lower in the exposure group than the non-exposure group.
INTRODUCTION
Acute myocardial infarction (AMI) is a commonly reported incident demanding immediate intervention by the department of cardiology. At presentation, patients with AMI often suffer from serious events such as cardiac death, cardiogenic shock, reinfarction, and stroke. With the widespread application of thrombolysis and interventional therapies, the in-hospital mortality of patients with AMI has been decreased by 10%-20%, but their long-term prognosis in patients is still under investigation. 1 In Traditional Chinese Medicine (TCM), practitioners believe that Qi deficiency and blood stasis are the main pathogenesis of AMI. Thus, tonifing Qi and activating blood circulation (SQABC) is the principal therapeutic approach. 2 SQABC has been widely used in the treatment and secondary prevention of AMI, with impending long-term prognosis. 3 However, several previous studies have evaluated the efficacy of a specific medication, with questions remaining on the overall efficacy of TCM in the management of AMI. Moreover, the efficacy of TCM based on symptom pattern identification of AMI was not systematically evaluated. The cohort study as an observational study is suitable for discussing the individualization of TCM to patients with AMI and the dynamic changes in treatment plans. 4 A previous study has reported that the incidence of reinfarction in a group treated with TCM was 1.6%, compared to that (3.6% ) for a group receiving no treatment. 5 In the present work, it aimed to investigate the effect of SQABC on AMI, and the relevance of end-point events in the context of multiple factors was evaluated to find evidence of the overall effect of TCM on AMI.
MATERIALS AND METHODS

Study design
During hospitalization, the administration of TCM to patients was in the form of injections. The exposed group was defined in terms of number of days of administration of TCM injections, with low exposure group receiving injections for 7-13 d and high exposure group receiving injections ≥ 14 d. During follow-ups, the administration of TCM to patients with AMI was in the form of decoctions or Chinese patent medicine. The definition of exposure group included the low exposure group with application between 28 d and < 3 months, the medium exposure group between 3 months and < 6 months, and high exposure group ≥ 6 months. Considering the literature on obtaining a powerful sample for cohort studies, 6, 7 an estimated sample size of 820 was arrived at for the present study. In a setting with an in-hospital mortality of 15% and a loss to follow-up rate of 20%, 1206 patients with AMI were required to be included in this study. Qi deficiency and blood stasis syndrome can be diagnosed, with the main symptoms necessary and secondary symptoms more than 2 items, combined with the tongue and pulse. 9 Injections, Chinese patent medicines, and decoctions used for the purpose of SQABC in TCM were also recognized. The efficacy of Traditional Chinese Medicine injections and Chinese patent medicines was based on drug instructions. The efficacy of Traditional Chinese Medicine decoction was based on the prescription dictionary of Traditional Chinese Medicine. For injections during hospitalization, Shengmai, Shenmai, Danhong, and Ligustrazine were used. During follow-ups, Chinese patent medicines in the form of capsules and pills (such as Suxiao Jiuxin, Compound Danshen, Qishenyiqi, and Xuefuzhuyu) and decoctions (such as Shengmaisan, Xuefuzhuyu, and Gualou Xiebai Banxia) were used.
Patients
Outcomes
From the medical record management systems, patient information such as age, gender, contact address, clinical complications, end-point events, and use of TCM were retrieved for cases hospitalized between July 1, 2014 and June 30, 2015. TCM use and end-point events of patients discharged from hospitals were followed up telephonically and via outpatient visits from July 1, 2015 to September 31, 2015. Due to the possibility of bias, including inaccuracy of data and recall bias during patient follow-up, care was taken to study patient records comprehensively before recruitment. The double entry method was used to ensure accuracy of data. Researchers were trained to en- 
RESULTS
Clinical characteristics and follow-up
Out of a total of 1596 cases considered, 1210 cases were identified as appropriate for follow-up. The follow-up time ranged from 6 months to 6 years and 9 months [average（34 ± 18）months]. During the investigations, 242 (16.67% ) cases were lost to follow-up (Table 1) .
TCM Treatments
During hospitalization, the person-times of administration of TCM injections were 2622. We identified 39 types of TCM injections, including Shenmai (13.35% ), Shengmai (11.37% ), and Shuxuetong (10.30% ), being administered to patients with AMI ( Table 2 ). The person-times of administration of Chinese patent medicines was 1143. We identified 38 types of oral Chinese patent medicines, including Compound Danshen (28.78% ), Shexiang Baoxin (21.00% ), and Suxiao Jiuxin (14.79% ), being prescribed to patients during follow-up. The person-times of administration of TCM decoctions was 182. We identified 18 types of TCM decoctions, including Shengmai San (31.39% ), Taohongsiwutang (18.98% ), and Gualou Xiebai Banxia (15.33% ), being prescribed for patients with AMI (Table 3) . Based on the definition of exposure, there were 561 cases in the high-exposure group, 622 cases in the low-ex- 
End-point events
During hospitalization, the highest incidence of endpoint events was reported for post-infarction angina (31.86% ), followed by acute heart failure (14.39% ) and cardiac death (12.76%). During follow-ups, the incidence rates of end-point events were in the following order: cardiovascular rehospitalization (29.45% ), postinfarction angina (18.69% ), and cardiac death (14.99%). (Tables 4, 5) .
Multiple logistic regression analysis
The related factors were identified as independent variables. The strains were end-point events that occurred during hospitalization and follow-ups, as shown in (Table 8) .
DISCUSSION
In clinical practice, a period of 28 days following the occurrence of AMI is generally referred to as the acute phase, followed by the recovery period.
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In this study, the association between TCM application and end-point events during hospitalization and follow-up were investigated separately, because the pathological characteristics of AMI would differ between hospitalization and follow-up periods. During hospitalization, the incidences of cardiac death and cardiac shock were significantly lower in the exposure group than in the non-exposure group. Similarly, during follow-ups, the incidences of cardiac death, acute heart failure, composite end-point of reinfarction and stroke, and rehospitalization due to angina were significantly lower in the exposure group than in the non-exposure group. Therefore, SQABC significantly improved the short-term and long-term prognosis of patients with AMI, consistent with previous findings. In a cohort study that followed 248 patients with AMI, Buchangnaoxintong significantly decreased the incidences of end-point events such as death, reinfarction, severe heart failure, revascularization, and stroke. 10 Another prospective cohort study has shown that TCM shows benefits in reducing the incidences of rehospitalization due to angina during a 6-month period. 13 According to the principles of TCM, the primary pathological factors in the acute and recovery stages of AMI are Qi deficiency and blood stasis. Thus, the treatment is principally directed at tonifying Qi and promoting blood circulation. This is the main therapeutic aim of Table 6 Assignment of independent and dependent variables 
